SAN MATEO, Calif.—Health Fidelity Inc., a company that provides innovative technologies for the value-based care era, has expanded its leadership team to support increasing demand for its Lumanent® suite of risk adjustment solutions. Tejveer Singh, formerly of Key Health, returned to Health Fidelity to serve as vice president, engineering. Jackie Engel, previously vice president, corporate counsel, has been promoted to general counsel. Adam Gronsky, former vice president of innovation has been named chief innovation officer, and Andrea Serra, director of marketing has been promoted to vice president of marketing.
Each position plays a vital role in furthering critical initiatives that support Health Fidelity’s success: scaling applications, new business and channel partnership acceleration, product innovation and expansion, and new technology use-case development and partnerships.
Steve Whitehurst, chief executive officer of Health Fidelity noted, “The growth phase Health Fidelity is in is a balancing act of addressing current demand while effectively keeping one step ahead of the market. It makes positions like these not just necessary but exciting.” He continued, “Promoting from within validates the exceptional talent here at Health Fidelity, gives us continuity of expertise, and reinforces our values as we continue to grow and mature into a larger organization.”
Alongside these promotions, Health Fidelity has expanded its commercial team, adding two additional strategic sales executive roles, one each for payer and provider market segments. Chief commercial officer Robin Lloyd added, “The pandemic’s impact on fee-for-service models has increased demand for effective solutions that support value-based care performance. We’re committed to growing our commercial reach to support organizations looking to succeed in risk-based payment models and delivering associated care.”
To learn more, follow @healthfidelity on Twitter or Linkedin.
###
media@healthfidelity.com
(650) 727-3300
